Treatment Action Group
Acronym: TAG
General Information
Identification Code: 916467249117-03
Website: [object Object]
Entity Form: 501C3
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 2/16/2023
Last Update: 1/26/2024
EP Accredited Number: 0
Mission & Interests
Goals: Treatment Action Group (TAG) envisions the end of the HIV, tuberculosis (TB), and hepatitis C (HCV) pandemics with the discovery, development, and worldwide dissemination of safe and effective diagnostics, preventives, and cures through public health structures that end systemic harms and promote human rights, and that are developed by the diverse communities most affected by these conditions. This vision will be realized based on data and science, and achieved through community engagement, distributive justice, and equitable access to the benefits of science.
Interests Represented: Does not represent commercial interests
Interests:
- International co-operation and development
- Public health
- Research and innovation
Levels of Interest:
- european
- global
Activities
Main EU Legislative Proposals: EU Global Health Strategy; Horizon Europe R&I policies; EU policies on antimicrobial resistance and other health research.
Communication Activities: TAG publishes an annual report on global funding for tuberculosis research and development (R&D), which contains analysis of and information on EU funding for TB R&D (https://www.treatmentactiongroup.org/resources/tbrd-report/).
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 90 Broad StSuite 2503
Post Code: 10004
City: New York
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: 90 Broad StSuite 2503
Post Code: 10004
City: New York
Country: UNITED STATES
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: Please note that the estimate of annual costs related to activities covered by the Register is estimated to be very low as Treatment Action Group (TAG) is a USA-based organization that engages with the EU on narrow, discrete topics and not as a matter of our primary mission. Our engagement is limited to EU policies and programmes related to global health research, specifically within the sub-field of infectious diseases and primarily focused on tuberculosis (TB). Estimates of staff time reflect reasonable estimates of effort given to these activities and to supervising the work of a Brussels-based consultant, Karen Hoehn of Bonstar Consulting, with whom TAG has a contractual relationship to outsource relevant representation activities. Our contract with Karen Hoehn totals USD $24,000 (~EUR 22,100) for the period February 2024 through December 2024, subject to renewal at similar level of effort.
Membership Information
Members10 Percent: 1
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 2
Members F T E: 0.3499999940395355
Structure
Structure Type: Structure
Is Member Of: Treatment Action Group participates in an informal advocacy coalition advancing research on new TB vaccines called TB Vax ARM (https://newtbvaccines.org/take-action/) that interfaces with EU institutions on policy issues.
Organisation Members: TAG is a member of the Washington, D.C.-based Global Health Technologies Coalition (https://www.ghtcoalition.org/our-members).